US Medicare Wastage ‘Refund’ Collections Delayed To ‘Align’ With IRA
Executive Summary
A new Medicare rebate for discarded portions of single-use vials is taking effect as scheduled in January – but the first invoices won’t be issued in the fall as planned. CMS says it wants to wait to ‘align’ the collections process with the new inflation rebates enacted by the IRA.
You may also be interested in...
Medicare Needs ‘Robust’ Claims Oversight So Inflation Rebates Won’t Duplicate 340B Discounts
PhRMA urges CMS to take a more proactive approach to monitoring 340B claims than previously proposed. Meanwhile, hospitals object to the claims modifier requirement.
Medicare Wastage Rebate Exceptions For Small Volume Products, Cell/Gene Therapy Urged
Packaging for such products reflects ‘unique circumstances’ that should exempt them from the rebates on discarded drugs otherwise required by the policy, stakeholders tell CMS at a ‘town hall’ forum.
Medicare ASP Reporting: CMS Weighing Guidance, Beefed Up Internal Controls To Ensure Accuracy
US Health and Human Services Department Inspector General issues two reports on manufacturer-reported average sales prices and how their accuracy could be improved. ASPs serve as the basis for Medicare Part B reimbursement and will also be used to guide implementation of price inflation-based rebate penalties for Part B drugs beginning in the first quarter of 2023.